[Monoclonal gammopathies in the aged]

Area of Science:

• Hematology
• Oncology
• Geriatrics

Context:

• Presents 60 cases of monoclonal gammopathies (benign and malignant).
• Patients treated at "Renzetti" civic Hospital in Lanciano.
• Data divided into two age subgroups: under and over 65 years old.

Purpose:

• To analyze differences in monoclonal gammopathies based on age.
• To compare median survival rates between age groups.
• To evaluate response to therapy in different age subgroups.

Summary:

• Investigated 60 monoclonal gammopathy cases, stratifying by age (<65 and >65).
• Compared gammapathy types, median survival, and therapy response across age groups.
• Discusses age-related variations in disease progression and treatment efficacy.

Impact:

• Highlights the prognostic significance of age in monoclonal gammopathies.
• Informs clinical management strategies for elderly patients with monoclonal gammopathies.
• Provides insights into age-specific therapeutic approaches for improved patient outcomes.